Alexander Krichevsky
Direktor/Vorstandsmitglied bei Omnimmune Corp.
Profil
Alexander Krichevsky currently works at Omnimmune Corp., as Director from 2001.
Mr. Krichevsky also formerly worked at The Trustees of Columbia University in The City of New York, as Director-Tissue Culture & Hybridoma Laboratories, Omnimmune Holdings, Inc., as Director, Vice President & Research Director in 2010, Allegheny-Singer Research Institute, as Director-Monoclonal Antibody Development, and Invitro Technologies, as Senior Vice President-Research & Development.
Aktive Positionen von Alexander Krichevsky
| Unternehmen | Position | Beginn |
|---|---|---|
Omnimmune Corp.
 Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Direktor/Vorstandsmitglied | 29.12.2009 |
Ehemalige bekannte Positionen von Alexander Krichevsky
| Unternehmen | Position | Ende |
|---|---|---|
| OMNIMMUNE HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.08.2010 |
| Invitro Technologies | Technik-/Wissenschafts-/F&E-Leiter | - |
| Allegheny-Singer Research Institute | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OMNIMMUNE HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Omnimmune Corp.
Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Health Services |
| Allegheny-Singer Research Institute | |
| Invitro Technologies |
